Filtered By:
Condition: Anaphylactic Shock
Vaccination: Varicella-Zoster Virus Vaccine
This page shows you your search results in order of date.
Order by Relevance | Date
Total 65 results found since Jan 2013.
Management of coronavirus disease 2019 vaccine-induced cutaneous complications: A comprehensive literature review
J Family Community Med. 2023 Jul-Sep;30(3):161-170. doi: 10.4103/jfcm.jfcm_3_23. Epub 2023 Jul 24.ABSTRACTDespite the numerous reports of cutaneous manifestations associated with vaccines for coronavirus disease 2019 (COVID-19), the relationship between COVID-19 vaccines and cutaneous side effects remains unevaluated. In this review, we examine these manifestations and their management. Reported dermatoses included injection-site reaction (early and delayed), type I allergic reaction, morbilliform eruption, pityriasis rosea, Sweet syndrome, lichen planus, psoriasis, herpes zoster reactivation, erythema multiforme, Stevens-...
Source: Herpes - September 7, 2023 Category: Infectious Diseases Authors: Nouf F Bin Rubaian Abdullah A Aljalfan Serene R Almuhaidib Source Type: research
Post-licensure safety study of new-onset immune-mediated diseases, herpes zoster, and anaphylaxis in adult recipients of HepB-CpG vaccine versus HepB-alum vaccine
CONCLUSIONS: This large post-licensure study did not identify evidence of safety concerns for HepB-CpG compared to HepB-alum for immune-mediated diseases, HZ, or anaphylaxis.PMID:37308363 | DOI:10.1016/j.vaccine.2023.06.004
Source: Vaccine - June 12, 2023 Category: Allergy & Immunology Authors: Bradley Ackerson Lina S Sy Jeff Slezak Lei Qian Kristi Reynolds Runxin Huang Zendi Solano William Towner Sijia Qiu Sarah R Simmons Steven J Jacobsen Katia J Bruxvoort Source Type: research
Necrotizing pancreatitis, microangiopathic hemolytic anemia and thrombocytopenia following the second dose of Pfizer/BioNTech COVID-19 mRNA vaccine
We report a 31-year-old female with a history of borderline personality disorder, intravenous drug abuse, allergic asthma, eating disorder, psoriatic arthritis treated with tofacitinib, neurogenic bladder disturbance, cholecystectomy, recurrent thoracic herpes zoster, vaginal candida infections and urinary tract infections, who developed pancreatitis associated with thrombotic microangiopathy and hemolytic-uremic syndrome 10 days after the second vaccination, whereas the first has been well tolerated. She was treated by plasma exchange, and eventually by transgastric drainage with implantation of a plastic stent to remove ...
Source: Herpes - June 6, 2023 Category: Infectious Diseases Authors: Claudia St öllberger Kastriot Kastrati Clemens Dejaco Martina Scharitzer Josef Finsterer Patrick Bugingo Madeleine Melichart-Kotik Astrid Wilfing Source Type: research
Cutaneous manifestations of COVID-19 and COVID-19 vaccination
J Dermatol. 2023 Jan 13. doi: 10.1111/1346-8138.16651. Online ahead of print.ABSTRACTIn December 2019, a new infectious pathogen named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was identified in Wuhan, China. Transmitted through respiratory droplets, SARS-CoV-2 is the causative pathogen of coronavirus disease 2019 (COVID-19). Although this new COVID-19 infection is known to cause primarily interstitial pneumonia and respiratory failure, it is often associated with cutaneous manifestations as well. These manifestations with COVID-19 can be classified into seven categories: (i) chilblain-like skin eruption...
Source: Herpes - January 13, 2023 Category: Infectious Diseases Authors: Chisa Nakashima Maiko Kato Atsushi Otsuka Source Type: research
COVID-19 vaccines adverse events: potential molecular mechanisms
Immunol Res. 2023 Jan 6. doi: 10.1007/s12026-023-09357-5. Online ahead of print.ABSTRACTCOVID-19 is an infectious disease caused by a single-stranded RNA (ssRNA) virus, known as SARS-CoV-2. The disease, since its first outbreak in Wuhan, China, in December 2019, has led to a global pandemic. The pharmaceutical industry has developed several vaccines, of different vector technologies, against the virus. Of note, among these vaccines, seven have been fully approved by WHO. However, despite the benefits of COVID-19 vaccination, some rare adverse effects have been reported and have been associated with the use of the vaccines ...
Source: Herpes - January 6, 2023 Category: Infectious Diseases Authors: Malamatenia Lamprinou Athanasios Sachinidis Eleni Stamoula Theofanis Vavilis Georgios Papazisis Source Type: research
Safety of mRNA COVID-19 Vaccines in Patients with Inborn Errors of Immunity: an Italian Multicentric Study
CONCLUSION: Although our follow-up period is relatively short, the safety data we reported are reassuring. This data would help to contrast the vaccine hesitancy often manifested by patients with IEI and to better inform their healthcare providers.PMID:36374363 | DOI:10.1007/s10875-022-01402-6
Source: Herpes - November 14, 2022 Category: Infectious Diseases Authors: Cinzia Milito Francesco Cinetto Giulia Garzi Andrea Palladino Marco Puca Elena Brambilla Camilla De Vitis Giulia Costanzo Riccardo Scarpa Alessandra Punziano Gianluca Lagnese Stefano Del Giacco Giuseppe Spadaro Isabella Quinti Davide Firinu Source Type: research
Active Post-Licensure Safety Surveillance for Recombinant Zoster Vaccine Using Electronic Health Record Data
Am J Epidemiol. 2022 Oct 4:kwac170. doi: 10.1093/aje/kwac170. Online ahead of print.ABSTRACTRecombinant zoster vaccine (RZV) (Shingrix; GlaxoSmithKline, Brentford, United Kingdom) is an adjuvanted glycoprotein vaccine that was licensed in 2017 to prevent herpes zoster and its complications in older adults. In this prospective, post-licensure Vaccine Safety Datalink (VSD) study using electronic health records, we sequentially monitored a real-world population of adults aged 50 years and older who received care at multiple VSD health systems in the United States to identify potential increased risks of 10 pre-specified prior...
Source: Herpes - October 4, 2022 Category: Infectious Diseases Authors: Jennifer C Nelson Ernesto Ulloa-P érez Onchee Yu Andrea J Cook Michael L Jackson Edward A Belongia Matthew F Daley Rafael Harpaz Elyse O Kharbanda Nicola P Klein Allison L Naleway Hung-Fu Tseng Eric S Weintraub Jonathan Duffy W Katherine Yih Lisa A Jacks Source Type: research
